Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 28% ± 5% | |
hepatocyte | 5 studies | 50% ± 25% | |
ciliated cell | 4 studies | 25% ± 6% | |
GABAergic neuron | 4 studies | 37% ± 18% | |
glutamatergic neuron | 4 studies | 38% ± 20% | |
endothelial cell | 3 studies | 21% ± 3% | |
goblet cell | 3 studies | 19% ± 1% | |
intestinal crypt stem cell | 3 studies | 17% ± 2% | |
astrocyte | 3 studies | 30% ± 8% | |
interneuron | 3 studies | 46% ± 24% | |
oligodendrocyte precursor cell | 3 studies | 32% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 2176.21 | 648 / 653 | 96% | 8.81 | 583 / 605 |
prostate | 96% | 1992.27 | 234 / 245 | 100% | 17.25 | 500 / 502 |
liver | 99% | 13552.41 | 224 / 226 | 92% | 34.25 | 373 / 406 |
stomach | 91% | 1357.36 | 325 / 359 | 94% | 15.59 | 269 / 286 |
esophagus | 85% | 2179.87 | 1226 / 1445 | 97% | 14.67 | 178 / 183 |
skin | 96% | 2629.19 | 1743 / 1809 | 79% | 7.24 | 375 / 472 |
ovary | 79% | 705.27 | 142 / 180 | 95% | 11.61 | 408 / 430 |
breast | 78% | 943.67 | 360 / 459 | 95% | 10.62 | 1058 / 1118 |
brain | 99% | 3248.16 | 2621 / 2642 | 72% | 5.11 | 507 / 705 |
intestine | 70% | 2850.66 | 678 / 966 | 98% | 19.54 | 514 / 527 |
bladder | 67% | 853.14 | 14 / 21 | 92% | 13.15 | 463 / 504 |
kidney | 100% | 1655.13 | 89 / 89 | 48% | 4.65 | 432 / 901 |
uterus | 56% | 475.65 | 96 / 170 | 87% | 11.90 | 400 / 459 |
adrenal gland | 66% | 488.08 | 171 / 258 | 66% | 4.28 | 152 / 230 |
lung | 44% | 430.86 | 254 / 578 | 88% | 10.32 | 1019 / 1155 |
pancreas | 40% | 254.42 | 131 / 328 | 85% | 6.46 | 152 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.08 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 16.39 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.11 | 1 / 1 |
spleen | 93% | 825.58 | 223 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 6.80 | 71 / 80 |
heart | 86% | 2051.90 | 744 / 861 | 0% | 0 | 0 / 0 |
muscle | 66% | 795.03 | 527 / 803 | 0% | 0 | 0 / 0 |
adipose | 49% | 572.93 | 584 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 39% | 584.34 | 359 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 12% | 80.26 | 156 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008202 | Biological process | steroid metabolic process |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0099617 | Cellular component | matrix side of mitochondrial inner membrane |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0003858 | Molecular function | 3-hydroxybutyrate dehydrogenase activity |
Gene name | BDH1 |
Protein name | D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) (Short chain dehydrogenase/reductase family 9C member 1) 3-hydroxybutyrate dehydrogenase (EC 1.1.1.30) D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) 3-hydroxybutyrate dehydrogenase 1 |
Synonyms | BDH SDR9C1 |
Description | |
Accessions | ENST00000445160.2 ENST00000630698.2 ENST00000627658.2 C9K0G7 E9PCG9 ENST00000446746.5 A0A494C1C0 ENST00000392378.6 H7C2W1 ENST00000629309.2 C9JEB9 C9JB83 C9JQ90 ENST00000626799.2 C9JM78 A0A0G2JRX6 ENST00000358186.6 ENST00000441275.5 ENST00000432819.5 ENST00000431056.5 ENST00000392379.6 Q02338 ENST00000455876.1 ENST00000625957.2 ENST00000617317.2 ENST00000612690.3 ENST00000631323.2 ENST00000651856.1 ENST00000434143.5 |